Relationship between glutathione S-transferase P1 polymorphism and bronchial asthma and atopic dermatitis

Bulletin of Experimental Biology and Medicine

Volumn 136, Issue 1, 2003, Pages 73-75

  Safronova, O G ^a   Vavilin, V A ^a   Lyapunova, A A ^a   Makarova, S I ^a   Lyakhovich, V V ^a   Kaznacheeva, L F ^b   Manankin, N A ^c   Batychko, O A ^b   Gavalov, S M ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^c Municipal Children's Hospital No 1   (Russian Federation)

Author keywords

Atopic dermatitis; Bronchial asthma; Glutathione S transferase P1 polymorphism; Predisposition; Xenobiotics

Indexed keywords

ADENINE; GLUTATHIONE TRANSFERASE; GUANINE; ISOLEUCINE; VALINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CIGARETTE SMOKING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA ISOLATION; DRUG INTOXICATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL;

ALLELES; ASTHMA; CHILD; DERMATITIS, ATOPIC; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; ISOLEUCINE; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RUSSIA; VALINE; XENOBIOTICS;

EID: 0346639159     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026001216033     Document Type: Article

References (15)

1. V. A. Vavilin, S. I. Makarova, V. V. Lyakhovich, and S. M. Gavalov, Genetika, 38, No. 4, 539-545 (2002).
2. V. A. Vavilin, O. B. Chasovnikova, V. V. Lyakhovich, et al., Vopr. Med. Khim., 46, No. 4, 388-397 (2000).
3. V. V. Lyakhovich, V. A. Vavilin, S. I. Makarova, et al., Vestn. Ros. Akad. Med. Nauk, No. 12, 36-41 (2000).
4. R. Fletcher, S. Fletcher, and E. Vagner, Clinical Epidemiology. Basic Principles of Probative Medicine [in Russian], Moscow (1998).
5. D. L. Eaton and T. K. Bammler, Toxicol. Sci., 49, No. 2, 156-164 (1999).
6. A. A. Fryer, A. Blanco, M. Hepple, et al., Am. J. Respir. Crit. Care Med., 161, No. 5, 1437-1442 (2000).
7. L. W. Harries, M. J. Stubbins, D. Forman, et al., Carcinogenesis, 18, No. 4, 641-644 (1997).
8. T. Katoh, S. Kaneko, S. Takasawa, et al., Pharmacogenetics, 9, No. 2, 165-169 (1999).
9. T. Nakajima, E. Elovaara, S. Anttila, et al., Carcinogenesis, 16, No. 4, 707-711 (1995).
10. K. Shimizu, F. Toriyama, and H. Yoshida, Virchows Arch., 425, No. 6, 589-592 (1995).
11. R. L. Smyth, Respir. Res., 3, Suppl. 1, S3-S7 (2002).
12. K. Sundberg, K. Dreij, A. Seidel, and B. Jernstrom, Chem. Res. Toxicol., 15, No. 2, 170-179 (2002).
13. C. Sweeney, D. C. Farrow, S. M. Schwartz, et al., Cancer Epidemiol. Biomarkers Prev., 9, No. 4, 449-454 (2000).
14. N. S. Thomas, J. Wilkinson, and S. T. Holgate, Am. J. Respir. Crit. Care Med., 156, No. 4, Pt. 2, S144-S151 (1997).
15. M. Van Hage-Hamsten, E. Johansson, and M. Kronqvist, Clin. Exp. Allergy, 32, No. 6, 838-842 (2002).